Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma C Wall

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Plos One|February 15, 2023
STIMULATE-ICP: A pragmatic, multi-centre, cluster randomised trial of an integrated care pathway with a nested, Phase III, open label, adaptive platform randomised drug trial in individuals with Long COVID: A structured protocolDenise Forshaw, Emma C Wall, Gordon Prescott, et al.
Medrxiv : the Preprint Server for Health Sciences|June 30, 2025
SARS-CoV-2 antibody immunity across three continents: the West Africa, West Indies, West London ConsortiumDavid Greenwood, Oliver Hague, Eliza Mari Kwesi-Maliepaard, et al.
Frontiers in Cellular and Infection Microbiology|December 28, 2020
CSF Levels of Elongation Factor Tu Is Associated With Increased Mortality in Malawian Adults With <i>Streptococcus pneumoniae</i> MeningitisEmma C Wall, Philip Brownridge, Gavin Laing, et al.
Lancet (London, England)|January 23, 2022
Omicron neutralising antibodies after COVID-19 vaccination in haemodialysis patientsEdward J Carr, Mary Wu, Ruth Harvey, et al.
BMJ Open|January 14, 2026
Trajectory, healthcare utilisation and recovery in 3590 individuals with long covid: a 4-year prospective cohort analysisJai Prashar, Toby Hillman, Emma C Wall, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 6, 2014
Bacterial meningitis in Malawian adults, adolescents, and children during the era of antiretroviral scale-up and Haemophilus influenzae type b vaccination, 2000-2012Emma C Wall, Dean B Everett, Mavuto Mukaka, et al.
Lancet (London, England)|October 9, 2022
WHO's Therapeutics and COVID-19 Living Guideline on mAbs needs to be reassessedMary Y Wu, Edward J Carr, Ruth Harvey, et al.
Vaccine|March 8, 2025
Accurate evaluation of live-virus microneutralisation for SARS-CoV-2 variant JN.1 in the assessment of vaccination and therapeuticsGiulia Dowgier, Agnieszka Hobbs, David Greenwood, et al.
Lancet (London, England)|March 14, 2024
Divergent performance of vaccines in the UK autumn 2023 COVID-19 booster campaignMarianne Shawe-Taylor, David Greenwood, Agnieszka Hobbs, et al.
Lancet (London, England)|July 1, 2021
AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOCEmma C Wall, Mary Wu, Ruth Harvey, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Plos One|February 15, 2023
STIMULATE-ICP: A pragmatic, multi-centre, cluster randomised trial of an integrated care pathway with a nested, Phase III, open label, adaptive platform randomised drug trial in individuals with Long COVID: A structured protocolDenise Forshaw, Emma C Wall, Gordon Prescott, et al.
Medrxiv : the Preprint Server for Health Sciences|June 30, 2025
SARS-CoV-2 antibody immunity across three continents: the West Africa, West Indies, West London ConsortiumDavid Greenwood, Oliver Hague, Eliza Mari Kwesi-Maliepaard, et al.
Frontiers in Cellular and Infection Microbiology|December 28, 2020
CSF Levels of Elongation Factor Tu Is Associated With Increased Mortality in Malawian Adults With <i>Streptococcus pneumoniae</i> MeningitisEmma C Wall, Philip Brownridge, Gavin Laing, et al.
Lancet (London, England)|January 23, 2022
Omicron neutralising antibodies after COVID-19 vaccination in haemodialysis patientsEdward J Carr, Mary Wu, Ruth Harvey, et al.
BMJ Open|January 14, 2026
Trajectory, healthcare utilisation and recovery in 3590 individuals with long covid: a 4-year prospective cohort analysisJai Prashar, Toby Hillman, Emma C Wall, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 6, 2014
Bacterial meningitis in Malawian adults, adolescents, and children during the era of antiretroviral scale-up and Haemophilus influenzae type b vaccination, 2000-2012Emma C Wall, Dean B Everett, Mavuto Mukaka, et al.
Lancet (London, England)|October 9, 2022
WHO's Therapeutics and COVID-19 Living Guideline on mAbs needs to be reassessedMary Y Wu, Edward J Carr, Ruth Harvey, et al.
Vaccine|March 8, 2025
Accurate evaluation of live-virus microneutralisation for SARS-CoV-2 variant JN.1 in the assessment of vaccination and therapeuticsGiulia Dowgier, Agnieszka Hobbs, David Greenwood, et al.
Lancet (London, England)|March 14, 2024
Divergent performance of vaccines in the UK autumn 2023 COVID-19 booster campaignMarianne Shawe-Taylor, David Greenwood, Agnieszka Hobbs, et al.
Lancet (London, England)|July 1, 2021
AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOCEmma C Wall, Mary Wu, Ruth Harvey, et al.
Pageof 5